CDER Office of Testing & Research
Executive Summary
Director James MacGregor, PhD, is leaving Center for Drug Evaluation & Research in January to join the National Center for Toxicological Research as deputy director-Washington operations. MacGregor has been on a four-month assignment as the CDER science leveraging coordinator (1"The Pink Sheet" Sept. 11, p. 24). OTR Acting Deputy Director Ajaz Hussain, PhD, has been serving as director of OTR
You may also be interested in...
CDER Office of Testing & Research
Ajaz Hussain, PhD, named OTR director after serving as acting director since September. Hussain succeeds James MacGregor, PhD, who is joining the National Center for Toxicological Research as deputy director-Washington operations after a four-month detail as the CDER science leveraging coordinator (1"The Pink Sheet" Dec. 11, 2000, In Brief). Hussain has been OTR deputy director for the past year
CDER Office of Testing & Research
Ajaz Hussain, PhD, named OTR director after serving as acting director since September. Hussain succeeds James MacGregor, PhD, who is joining the National Center for Toxicological Research as deputy director-Washington operations after a four-month detail as the CDER science leveraging coordinator (1"The Pink Sheet" Dec. 11, 2000, In Brief). Hussain has been OTR deputy director for the past year
FDA Looking At Outside Research Alliances Through Advisory Committees
FDA's Pharmaceutical Science/Nonclinical Studies Advisory Subcommittee is being watched as a model for using advisory committees to expand FDA's collaboration with outside sources.